Medical Care, Vol. 45, No. 10, Supplement 2: Comparative Effectiveness and Safety: Emerging Methods (Oct., 2007), pp. S143-S148 (6 pages) Background: In observational research, propensity score ...
ADAGIO: A phase IIb, open-label, single-arm, multicenter study assessing the efficacy and safety of adavosertib (AZD1775) as treatment for recurrent or persistent uterine serous carcinoma. This is an ...